. . . . . . . . . . . . "[Pretreatment with low-dose DAC may have the potential to be used as a `biosensitizer` of DNA-damaging agents such as CPT-11 when the apoptotic pathway is inactivated as a result of aberrant promoter methylation in the cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:36:53+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .